Skip to main content
. Author manuscript; available in PMC: 2017 May 1.
Published in final edited form as: BJU Int. 2015 Jul 3;117(5):754–760. doi: 10.1111/bju.13186

Table 2.

Patient and tumor characteristics for patients with negative findings at 3-month cystoscopy and available 3-month FISH results

Total Negative FISH Results Positive FISH Results p-value
No. of patients 67 39 28
Age: mean (±SD) 66 ± 11.3 66 ± 12.2 65 ± 10.2 0.688
Sex
 Female 13 (19%) 6 (15%) 7 (25%) 0.326
 Male 54 (81%) 33 (85%) 21 (75%)
Smoker (past or present) 38 (57%) 21 (54%) 17 (61%) 0.629
Grade
 Low 6 (9%) 4 (10%) 2 (7%) 0.999
 High 61 (91%) 35 (90%) 26 (93%)
cT Stage
 cTa 28 (42%) 17 (44%) 11 (39%) 0.303
 cT1 37 (55%) 22 (56%) 15 (54%)
 cTis 2 (3%) 0 (0%) 2 (7%)
Concurrent CIS 39 (58%) 21 (54%) 18 (64%) 0.393
Prior Recurrence
  No 4 (6%) 2 (5%) 2 (7%) 0.868
  Single recurrence 32 (48%) 18 (46%) 14 (50%)
  Multiple recurrence 31 (46%) 19 (49%) 12 (43%)
Recurrence 19 (28%) 3 (8%) 16 (57%) <0.001
Progression 15 (22%) 1 (3%) 14 (50%) <0.001
Radical cystectomy 13 (19%) 1 (3%) 12 (43%) <0.001
Death 5 (7%) 2 (5%) 3 (11%) 0.643
Cancer-specific death 3 (4%) 0 (0%) 3 (11%) 0.100

Of 100 patients in the entire cohort who had negative findings at 3-month cystoscopy, 67 had 3-month FISH results sufficient for analysis.